Jeff Caravella
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Profil
Jeff Caravella served as the Chief Financial Officer at BioTheryX, Inc. and Medicenna Therapeutics Corp.
He received an undergraduate degree and an MBA from Syracuse University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
28.09.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Ehemalige bekannte Positionen von Jeff Caravella
Unternehmen | Position | Ende |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Finanzdirektor/CFO | 26.10.2023 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Finanzdirektor/CFO | - |
Ausbildung von Jeff Caravella
Syracuse University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Private Unternehmen | 1 |
---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |